Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q1 2017
|
DERM |
|
Phase 3 Results |
Other |
None |
|
Q1 2017
|
EYEG |
|
Phase 3 Results |
Opthamology |
None |
|
Q1 2017
|
NKTR |
|
Phase 3 Results |
Other |
Fast Track |
|
Q1 2017
|
PBYI |
|
Phase 3 Results |
Oncology |
None |
|
Q1 2017
|
TRVN |
|
Phase 3 Results |
Other |
Breakthrough Therapy, Fast Track |
|
Q1 2017
|
VRTX |
|
Phase 3 Results |
Other |
Breakthrough Therapy, Orphan Drug |
|
Q1 2017
|
BDSI |
|
Phase 2b Results |
Endocrine |
None |
|
Q1 2017
|
CLBS |
|
Phase 2 Results |
Endocrine |
Orphan Drug |
|
Q1 2017
|
CAPR |
|
Phase 2 Results |
Cardiovascular |
Orphan Drug |
|
Q1 2017
|
GWPH |
|
Phase 2 Results |
Neurology |
None |
|